Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 Booster”

224 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 224 results

Testing effectiveness (Phase 2)Temporarily pausedNCT05672355
What this trial is testing

A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaCOVID-19 Infection
City of Hope Medical Center 80
Very early researchUnknownNCT06272253
What this trial is testing

UNAIR Inactivated COVID-19 Vaccine INAVAC as Heterologue Booster (Immunobridging Study) in Adolescent Subjects

Who this might be right for
COVID-19 PandemicCOVID-19 Vaccines
Dr. Soetomo General Hospital 250
Not applicableStudy completedNCT05438472
What this trial is testing

Incidence, Patient Characteristics and Outcome of Myocarditis After COVID-19 mRNA Vaccine

Who this might be right for
Myocarditis
University Hospital, Basel, Switzerland 835
Post-approval studies (Phase 4)Study completedNCT05080218
What this trial is testing

COVID-19 VaccinE Response in Rheumatology Patients

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisSpondylarthritis
Jeffrey Curtis 841
Early research (Phase 1)UnknownNCT05182567
What this trial is testing

GLS-5310 Vaccine in Healthy Volunteers as a Booster for SARS-CoV-2 (COVID-19)

Who this might be right for
COVID-19Healthy
GeneOne Life Science, Inc. 69
Post-approval studies (Phase 4)Study completedNCT06065176
What this trial is testing

The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection

Who this might be right for
COVID-19Vaccine-Preventable DiseasesSARS CoV 2 Infection+2 more
Sarang K. Yoon, DO, MOH 1,188
Not applicableUnknownNCT05471440
What this trial is testing

SWITCH ON: Analysing the Immunogenicity of Additional Booster Vaccinations in HCW

Who this might be right for
Covid-19 Vaccination
Erasmus Medical Center 431
Large-scale testing (Phase 3)WithdrawnNCT05545683
What this trial is testing

Safety and Immunogenicity of Inactivated Heterologous Booster Vaccination

Who this might be right for
COVID-19
Centro de Estudios en Infectogía Pediatrica
Testing effectiveness (Phase 2)WithdrawnNCT05254236
What this trial is testing

Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated Vaccine in Healthy Adults in in Hong Kong

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd.
Testing effectiveness (Phase 2)UnknownNCT05345873
What this trial is testing

Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine as a Booster Dose in Population Aged 12-17 Years

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 300
Post-approval studies (Phase 4)Temporarily pausedNCT05165732
What this trial is testing

Safety and Immunogenicity Study of Booster Vaccination With COVID-19 Vaccine (Vero Cell),Inactivated From Different Manufactures for Prevention of COVID-19

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd. 480
Large-scale testing (Phase 3)UnknownNCT05236491
What this trial is testing

COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases

Who this might be right for
Rheumatoid ArthritisAutoimmune Rheumatologic DiseaseSystemic Lupus Erythematosus+6 more
Paul R Fortin 287
Testing effectiveness (Phase 2)Study completedNCT05525208
What this trial is testing

Booster Study of COVID-19 Protein Subunit Recombinant Vaccine

Who this might be right for
COVID-19
PT Bio Farma 696
Early research (Phase 1)Study completedNCT05233826
What this trial is testing

Safety and Immunogenicity of COVI-VAC as a Booster Dose in Adults Previously Vaccinated Against COVID-19

Who this might be right for
COVID-19SARS-CoV-2
Codagenix, Inc 20
Large-scale testing (Phase 3)Study completedNCT05265065
What this trial is testing

Evaluation of Full Versus Fractional Dose of COVID-19 Vaccine Given as a Booster for the Prevention of COVID-19 in Adults in Mongolia.

Who this might be right for
COVID-19
Murdoch Childrens Research Institute 601
Large-scale testing (Phase 3)Ended earlyNCT05683600
What this trial is testing

Efficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or Older

Who this might be right for
COVID-19
Guangzhou Patronus Biotech Co., Ltd. 3,000
Large-scale testing (Phase 3)Study completedNCT05077176
What this trial is testing

Phase 3 Booster Vaccination Against COVID-19

Who this might be right for
COVID-19Sars-CoV-2 Infection
Health Institutes of Turkey 4,340
Testing effectiveness (Phase 2)Study completedNCT04639466
What this trial is testing

A Synthetic MVA-based SARS-CoV-2 Vaccine, GEO-CM04S1, for the Prevention of COVID-19 Infection

Who this might be right for
COVID-19 Infection
GeoVax, Inc. 119
Not applicableStudy completedNCT05283902
What this trial is testing

Effectiveness, Immunogenicity and Safety of the Second Booster Dose of the Vaccine Against COVID-19 in the Elderly

Who this might be right for
COVID-19Vaccine Adverse ReactionVaccine-Preventable Diseases
Federal University of Espirito Santo 260
Not applicableUnknownNCT05571657
What this trial is testing

COVID-19 Booster Dose Reminder/Recall for Adolescents

Who this might be right for
COVID-19 Vaccines
Marshfield Clinic Research Foundation 4,304
Load More Results